Risperdal® (risperidone) and Invega® are powerful antipsychotic drugs approved to treat schizophrenia, bipolar disorder, and irritability associated with autism. However, they are also linked to a variety of adverse side effects. One of the most disturbing is gynecomastia, the abnormal growth of breast tissue in young males.
There are hundreds of Risperdal and Invega lawsuits pending in state courts that claim boys and young men who were prescribed Risperdal or Invega grew enlarged breasts after taking these medications. In some cases, mastectomies or other surgeries were needed to treat the problem.
Other Serious Side Effects of Risperdal and Invega
Prolactin is a hormone that causes lactation and breast tissue growth. Risperdal and Invega may increase prolactin levels in males, which can contribute to the onset of gynecomastia. But gynecomastia isn’t the only serious side effect linked to Risperdal or Invega. Other potential side effects may include:
- Neuroleptic Malignant Syndrome (NMS)
- Tardive Dyskinesia
- Bone loss and increased fracture risk
If you or a loved one has experienced any of these adverse effects, you may be eligible to file a lawsuit to seek justice and compensation for your injuries.
Off-Label Marketing of Risperdal
Risperdal is made and sold by Janssen Pharmaceuticals, a Johnson & Johnson (J&J) subsidiary. It was approved in 1993 by the U.S. Food and Drug Administration (FDA). However, about 70 percent of patients are prescribed the drug “off label” – or for uses not approved by the FDA. Many of those prescribed the drug off-label were children, since Risperdal was approved only for adult patients until 2007.
Risperdal sales practices have been under scrutiny by federal regulators since 2004, including allegations that the drug was marketed by the company for unapproved uses. In 2013, J&J agreed to pay $2.2 billion to settle an investigation by the U.S. Department of Justice into allegations that it illegally marketed Risperdal and other drugs.
Patients are urged to always seek a doctor’s advice before stopping or making changes to any medication regimen.
Risperdal® and Invega® are registered trademarks of Janssen Pharmaceuticals, Inc. , a pharmaceutical company of Johnson & Johnson.